Related Experiment Video

Updated: Jan 20, 2026

Master Transcription Regulators
02:23

Master Transcription Regulators

7.7K

STAT3, a Master Regulator of Anti-Tumor Immune Response

Cédric Rébé1, François Ghiringhelli2

  • 1Platform of Transfer in Cancer Biology, Centre Georges François Leclerc, INSERM LNC UMR1231,University of Bourgogne Franche-Comté, F-21000 Dijon, France. crebe@cgfl.fr.

Cancers
|September 5, 2019
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) plays a key role in immune cell regulation within the tumor microenvironment. This review explores STAT3

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Immune cells within the tumor microenvironment critically influence cancer progression.
  • Cancer growth is regulated by transcription programs controlling lymphoid and myeloid cell proliferation and activation.
  • Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor in these regulatory pathways.

Purpose of the Study:

  • To review the multifaceted role of STAT3 in immune cells within the tumor microenvironment.
  • To examine STAT3 regulation, including phosphorylation and acetylation, and its impact on immune cell function.
  • To explore STAT3's influence on tumor progression and its ability to modulate immune checkpoint inhibitors.

Main Methods:

  • Literature review focusing on STAT3 function in cancer immunology.
  • Analysis of STAT3 regulatory mechanisms (phosphorylation, acetylation).
  • Examination of STAT3's role in immune cell activity and tumor development.

Main Results:

  • STAT3 is a central regulator of immune cell proliferation and activation.
  • STAT3 activity is modulated by post-translational modifications like phosphorylation and acetylation.
  • STAT3 influences tumor progression and immune checkpoint inhibitor regulation.

Conclusions:

  • STAT3 is a critical mediator of immune responses in the tumor microenvironment.
  • Understanding STAT3 regulation offers potential therapeutic strategies for cancer.
  • Targeting STAT3 may impact tumor progression and enhance immunotherapy efficacy.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Master Transcription Regulators02:23

Master Transcription Regulators

2.7K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

In the age of immunotherapy and single-cell genomic profiling, cancer biology requires novel in vitro and computational tools for investigating the tumor-immune interface in a proper spatiotemporal context. We describe protocols to exploit tumor-immune microfluidic co-cultures in 2D and 3D settings, compatible with dynamic, multiparametric monitoring of cellular...
5.4K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Here we describe a method to separate and enrich components of the tumor immune and non-immune microenvironment in established subcutaneous tumors. This technique allows for the separate analysis of tumor immune infiltrate and non-immune tumor fractions which can permit comprehensive characterization of the tumor immune...
10.3K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.4K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Here we present a reproducible method for developing an orthotopic murine model of head and neck squamous cell carcinoma. Tumors demonstrate clinically relevant histopathological features of the disease, including necrosis, poor differentiation, nodal metastases, and immune infiltration. Tumor-bearing mice develop clinically relevant symptoms including dysphagia, jaw displacement, and weight...
12.2K